LUPRON DEPOT® (leuprolide acetate for depot suspension) 7.5 mg for 1-month, 22.5 mg for 3-month, 30 mg for 4-month, and 45 mg for 6-month administration are indicated for the palliative treatment of advanced prostatic cancer.

   Since 1985*
 35+ years of practice.
We call that
experience.

 

Jackson, age 67
Retired high school basketball coach,
husband, grandfather of 4
Not an actual patient.

Clinicians have prescribed LUPRON DEPOT for advanced prostate cancer patients
longer than any other GnRHa.2*†

*FDA-approved in 1985, the first GnRHa for the treatment of advanced prostate cancer.2
GnRHa=gonadotropin-releasing hormone agonist.

The number one prescribed GnRHa badge

Our Commitment

LUPRON DEPOT has been a pioneer for the treatment of advanced prostate cancer.2

The number one prescribed GnRHa badge The number one prescribed GnRHa badge The number one prescribed GnRHa badge
Based on IQVIA NSP data.

Hear From Your Peers

Dr Aaron Spitz and Dr Benjamin Lowentritt share their experiences using LUPRON DEPOT to treat patients with advanced prostate cancer.

Dr Aaron Spitz

Dr Benjamin Lowentritt

Individual results may vary.

Watch LUPRON DEPOT patients reveal insights about living with advanced prostate cancer

Demonstrated Efficacy and Safety Profile

LUPRON DEPOT has demonstrated effective testosterone suppression below castrate levels and safety profile across a number of clinical studies.1

Lucas, age 64
Semiretired financial analyst,
passionate cook, husband and father

Not an actual patient.

Demonstrated Efficacy and Safety Profile

LUPRON DEPOT has demonstrated effective testosterone suppression below castrate levels and safety profile across a number of clinical studies.1

Individualize Dosing

With 4 dosing options, you can choose the dosing schedule that is right for each advanced prostate cancer patient.1

Anthony, age 57
IT specialist, dog shelter
volunteer, single

Not an actual patient.